Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Longatto-Filho A, Maeda MY, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Matos J, Gontijo R, Sarian LO, Lima TP, Tatti S, Syrjänen S, Syrjänen K. Longatto-Filho A, et al. Among authors: syrjanen s, syrjanen k. Acta Cytol. 2005 Sep-Oct;49(5):500-6. doi: 10.1159/000326195. Acta Cytol. 2005. PMID: 16334026 Clinical Trial.
Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study.
Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS, Maeda MY, Longatto-Filho A, Syrjänen KJ. Gontijo RC, et al. Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):239-46. doi: 10.1016/j.ejogrb.2006.05.012. Epub 2006 Jun 30. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 16814450
Interlaboratory quality control in gynecologic cytopathology using the novel CONQUISTADOR software. Interobserver reproducibility in the Latin American screening study.
Alderisio M, Branca M, Erzen M, Longatto-Filho A, Derchain S, Tatti S, Vighi S, Roteli-Martins C, Leoncini L, Maeda MY, Montis D, Gontijo R, Sarian LO, Syrjänen K. Alderisio M, et al. Among authors: syrjanen k. Acta Cytol. 2007 Nov-Dec;51(6):872-81. doi: 10.1159/000325863. Acta Cytol. 2007. PMID: 18077979
Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study.
Syrjänen K, Derchain S, Roteli-Martins C, Longatto-Filho A, Hammes LS, Sarian L; Latin American Screening Study Group. Syrjänen K, et al. Acta Cytol. 2008 Nov-Dec;52(6):641-53. doi: 10.1159/000325616. Acta Cytol. 2008. PMID: 19068666
Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study.
Sarian LO, Hammes LS, Longatto-Filho A, Guarisi R, Derchain SF, Roteli-Martins C, Naud P, Erzen M, Branca M, Tatti S, de Matos JC, Gontijo R, Maeda MY, Lima T, Costa S, Syrjänen S, Syrjänen K. Sarian LO, et al. Among authors: syrjanen s, syrjanen k. Sex Transm Dis. 2009 Apr;36(4):241-8. doi: 10.1097/OLQ.0b013e3181935a7d. Sex Transm Dis. 2009. PMID: 19265732
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K. Sarian LO, et al. Among authors: syrjanen s, syrjanen k. J Med Screen. 2005;12(3):142-9. doi: 10.1258/0969141054855328. J Med Screen. 2005. PMID: 16156945
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study.
Longatto-Filho A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, Hammes L, Sarian LO, Bragança JF, Matos J, Gontijo R, Lima T, Maeda MY, Tatti S, Syrjänen S, Dores G, Lörincz A, Syrjänen K. Longatto-Filho A, et al. Among authors: syrjanen s, syrjanen k. Int J Gynecol Cancer. 2006 May-Jun;16(3):955-62. doi: 10.1111/j.1525-1438.2006.00582.x. Int J Gynecol Cancer. 2006. PMID: 16803469
Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K. Derchain SF, et al. Among authors: syrjanen s, syrjanen k. J Med Screen. 2008;15(2):97-104. doi: 10.1258/jms.2008.007061. J Med Screen. 2008. PMID: 18573778
Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study.
Longatto-Filho A, Roteli-Martins C, Hammes L, Etlinger D, Pereira SM, Erzen M, Branca M, Naud P, Derchain SF, Sarian LO, Matos J, Gontijo R, Lima T, Maeda MY, Tatti S, Syrjänen S, Syrjänen K. Longatto-Filho A, et al. Among authors: syrjanen s, syrjanen k. Eur J Gynaecol Oncol. 2008;29(4):327-32. Eur J Gynaecol Oncol. 2008. PMID: 18714563
750 results